PTEN and neoplasm: In silico exploration of the putative activation pathways by these upregulated TLRs, the canonical and inflammasome pathways in the mesenchymal subtype and the PTEN-TIRAP signaling in the classical subtype demonstrated their increase and their possible contribution to tumor growth.